Litcius/Paper detail

PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model

Xin Hu, Yifang Shui, Hiroshi Hirano, Kisato Kusano, Wen-Zhi Guo, Masayuki Fujino, Xiao‐Kang Li

2022Cancer Immunology Immunotherapy17 citationsDOIOpen Access PDF

Topics & Concepts

Tumor microenvironmentImmune systemCancer researchIntegrin alpha MMelanomaAntibodyImmune checkpointMonoclonal antibodyT cellCytokineImmunotherapyImmunologyBiologyMedicineCancer Immunotherapy and BiomarkersImmune cells in cancerImmune Cell Function and Interaction
PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model | Litcius